chers have developed a highly-sensitive rapid antigen test that can detect small loads of SARS-CoV-2
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million
PCI Managing Director leads panel discussion on Cellicon Valley with Penn Medicine faculty innovators
On May 6th, as part of the Cellicon Valley '21 two-day event, John Swartley, Managing Director of PCI, joined Penn Medicine faculty to discuss the commercialization of CAR-T technology
As part of Philly Tech Week 2021 and the Technical.ly Philly Introduced Conference, PCI and the Pennovation Center, hosted an educational webinar on the range of innovations emerging from Penn in the
As part of Philly Tech Week 2021, the Penn Center for Innovation and PACT featured pitch-length presentations from some of the most innovative startups emerging from Penn.
A Penn-founded biotech company that helps scientists test drugs and therapeutics has raised $4 million in order to more widely adopt their platform that embraces “organs on chip” technology. Vivodyne'
Carisma Therapeutics Inc. raised a Series B equity financing this year bringing the total amount raised in this round to $59 million and CARISMA's total capital raised to date to nearly $121 million.
Penn was picked as one of 16 universities to receive part of $75 million in funding for a five-year artificial intelligence research program from the Toyota Research Institute.
Penn is one of fifteen of the country’s leading research universities that launched the University Technology Licensing Program (UTLP).
Gyroscope entered into a two-year sponsored research agreement with the Penn Center for Advanced Retinal and Ocular Therapeutics.